PDE2A and fragile X syndrome: This suggests that PDE2A plays a critical role in cGMP breakdown during early postnatal development, accounting for approximately 50% of the reduction in cGMP levels during synaptogenesis in the rat brain, further suggesting that targeting PDE2A early in development could help correct the abnormal neurodevelopment observed in FXS [50].